Diligence memo · auto-generated · as of July 2, 2026

Predictive Health Diagnostics Co.

Predictive Health Diagnostics Co. looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Predictive Health Diagnostics Co. operates in Medical Devices, based in IRVINE.

Sub-sector tags: medical-devices.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Predictive Health Diagnostics Co. has raised $8.3M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $8.3M on 2021-02-25.

Most recent recorded round closed around 2021-02-25.

Valuation (modeled)modeled

Provath models Predictive Health Diagnostics Co. at approximately $155M (range $10M–$724M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 3.13× the median modeled value of Series A Medical Devices companies in 2019–2021 (17 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Last raise 5.3 yr ago; this sector typically re-raises about every 16 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 75% of Medical Devices peers (233 compared).

Modeled value ranks above 91% of those peers.

Closest niche peers: Reliant Immune Diagnostics, Inc., Pristine Surgical LLC, Juno Diagnostics, Inc., Allotrope Medical Inc., Surgical Innovation Associates Inc..

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.